📰
Politics
Lilly's Weight Loss Sets High Bar for Obesity Drug Race
📅9 June 2026 at 17:59
📰Bloomberg
👁️1 views
Share:
📰
Article Preview
Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst for Bloomberg Intelligence, joined Bloomberg's Scarlett Fu and Paul Sweeney to discuss the gains and losses in the GLP1 market. (Source: Bloomberg)
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.